- Our experts develop in vitro assays in high-throughput formats to support drug discovery projects.
- We create cell-based and biochemical assays in 384-well and 1536-well plates for HTS campaigns and data collection during hit-to-lead and lead optimization, aiding preclinical advancement.
- Our technology platforms support multiple readouts, including fluorescence intensity (FRET), luminescence (BRET), absorbance, fluorescence polarization, AlphaScreen, time-resolved fluorescence, immunofluorescence, and qPCR.
- We develop assays across various target classes like GPCRs, receptor tyrosine kinases, multiple enzyme classes, protein-protein interactions, and gene expression.
- We have extensive experience in Infectious Disease drug discovery, including screening within BSL-3 containment and bringing new virus variants online for relevant results.
- Our assays are compatible with small molecules and biologics, with readouts such as cytopathic effect, reporter virus, immunofluorescence, and AlphaScreen.
- Our goal is to produce accurate results with high throughput to inform critical decisions.
Assay Development Services
Drug discovery success hinges on the development of tools that reliably measure the biological phenomena being studied. Our research organization stands as your trusted partner in assay development, providing a comprehensive suite of services to tailor assays specifically to your research goals.
